Meeting
2021 ASCO Annual Meeting
Use of neoadjuvant chemotherapy in elderly patients with muscle invasive bladder cancer: A population-based study, 2006 to 2017.
Authors
Natasza Posielski
Virginia Mason Medical Center, Seattle, WA
Natasza Posielski , Nathan Jung , Hannah Koenig , On Ho , John Paul Flores , Christopher Porter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4536)
DOI
10.1200/JCO.2021.39.15_suppl.4536
Abstract #
4536
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.
First Author: Mayumi Forster
Poster
2022 ASCO Quality Care Symposium
Pathologic complete responses and overall survival after neoadjuvant chemotherapy for muscle-invasive bladder cancer: Analyzing the impact of race.
First Author: Arya Mariam Roy
Poster
2019 ASCO Annual Meeting
Increasing use of neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC): Prognostic impact of non-standard of care (SOC) regimens.
First Author: Yaw A. Nyame
Poster
2017 Genitourinary Cancers Symposium
The effect of adjuvant chemotherapy for patients with adverse pathology after neoadjuvant chemotherapy for muscle invasive bladder cancer.
First Author: William P. Parker